INTERFERON-ALPHA IN THE THERAPY OF CML

被引：17
|
作者：
TALPAZ, M
KANTARJIAN, H
KURZROCK, R
GUTTERMAN, JU
机构：
[1] Department of Clinical Immunology and Biological Therapy, University of Texas Cancer Center, M. D. Anderson Hospital
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1991年 / 79卷
关键词：
D O I：
10.1111/j.1365-2141.1991.tb08117.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This paper summarizes the experience with interferon-alpha (IFN-alpha) as single-agent therapy and in combination gathered at M.D. Anderson Cancer Center. It also covers some of the laboratory research associated with these clinical studies.
引用
收藏
页码：38 / 41
页数：4
相关论文
共 50 条
  • [1] The interferon-alpha revival in CML
    Talpaz, Moshe
    Mercer, Jessica
    Hehlmann, Ruediger
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 : S195 - S207
  • [2] The interferon-alpha revival in CML
    Moshe Talpaz
    Jessica Mercer
    Rüdiger Hehlmann
    [J]. Annals of Hematology, 2015, 94 : 195 - 207
  • [3] POTENTIAL MECHANISMS OF ACTION OF INTERFERON-ALPHA IN CML
    DOWDING, C
    GORDON, M
    GUO, AP
    MAISON, D
    OSTERHOLZ, J
    SICZKOWSKI, M
    GOLDMAN, J
    [J]. LEUKEMIA & LYMPHOMA, 1993, 11 : 185 - 191
  • [4] RANDOMIZED COMPARISON OF INTERFERON-ALPHA VS BUSULFAN - PROLONGATION OF SURVIVAL BY INTERFERON-ALPHA IN CHRONIC PHASE CML
    HEHLMANN, R
    HEIMPEL, H
    HASFORD, J
    KOLB, HJ
    HOSSFELD, DK
    HEINZE, B
    HOCHHAUS, A
    PRALLE, H
    QUEISSER, W
    LOFFLER, H
    ANSARI, H
    [J]. BLOOD, 1993, 82 (10) : A330 - A330
  • [5] Unusual cytogenetic evolution in CML treated with interferon-alpha
    Maloisel, F
    Laplace, A
    Uettwiller, F
    Lioure, B
    Oberling, F
    [J]. LEUKEMIA, 1997, 11 (06) : 893 - 894
  • [6] Depression and interferon-alpha therapy
    Cassidy, EM
    O'Keane, V
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2000, 176 : 494 - 494
  • [7] HYPERTRIGLYCERIDEMIA MAY BE SEVERE IN CML PATIENTS TREATED WITH INTERFERON-ALPHA
    PENARRUBIA, MJ
    STEEGMANN, JL
    LAVILLA, E
    CASADO, F
    REQUENA, MJ
    PICO, M
    ARRANZ, R
    FERNANDEZRANADA, JM
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1995, 49 (03) : 240 - 241
  • [8] The Combination of Interferon-Alpha and Ponatinib Enables Faster and Deeper Molecular Responses in Patient with De Novo Blast Crisis of CML: Interferon-Alpha May Return as a CML Treatment
    Hayashi, Kunio
    Ikegame, Kazuhiro
    Takahashi, Naoto
    [J]. CASE REPORTS IN HEMATOLOGY, 2021, 2021
  • [9] Autografting followed by interferon-alpha increase overall survival in CML patients
    Corsetti, MT
    Damasio, E
    Rossi, E
    Spriano, M
    Risso, M
    Beltrami, G
    Clavio, M
    Gobbi, M
    Lerma, E
    Cavaliere, M
    Carella, AM
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S150 - S150
  • [10] Use of interferon-alpha (reaferon) in patients with chronic myeloid leukemia (CML)
    Machulaitene, ER
    Lasunskaya, EB
    Nefedova, YB
    Perekalina, TA
    Salogub, GN
    Polyakova, LE
    [J]. TERAPEVTICHESKII ARKHIV, 1996, 68 (10): : 44 - 47
12345